SolveBio

SolveBio operated as a data infrastructure firm focused on the genomics and precision medicine sectors. Founded in 2013 by Mark Kaganovich, David Caplan, and others, the New York-based company aimed to solve the challenge of fragmented and difficult-to-access genomic data for clinical and research purposes. The founders' backgrounds in technology and research, including experience at institutions like the Broad Institute and companies like TwitterAudit, informed the company's direction. Kaganovich, as CEO, often highlighted the problem of valuable genomic data being scattered across outdated formats like FTP sites, making it unusable for modern, data-driven medicine.

The company developed a genomic intelligence platform designed to manage, distribute, and analyze vast and complex molecular data sets. This platform provided clients, primarily in the biopharmaceutical industry, with a cloud-based system that harmonized data from disparate sources, such as clinical studies, vendors, and patients. Its core service was delivered through a Software-as-a-Service (SaaS) model, featuring easy-to-use APIs with bindings for Python and R, which allowed developers and scientists to integrate clean, versioned, and standardized data directly into their applications and research workflows. The platform aimed to help clients accelerate therapeutic development, reduce clinical trial risks, and ultimately deliver more effective treatments to patients.

SolveBio's journey included securing approximately $4.5 million in funding over several rounds, with initial seed funding of $2 million in 2014 from notable investors like Andreessen Horowitz and Max Levchin. It also received grants from the National Institutes of Health (NIH) to expand its genomic applications. A key milestone for the company was its acquisition by QuartzBio, a division of Precision for Medicine, on January 24, 2023. The acquisition integrated SolveBio's technology into QuartzBio's suite of SaaS solutions, creating a more comprehensive data management platform that links clinical sample inventory with biomarker data to support therapeutic areas like oncology and autoimmune diseases.

Keywords: genomic data, precision medicine, data infrastructure, biopharma analytics, clinical development, biomarker data management, multi-omics data, bioinformatics, molecular data, clinical research, genomic intelligence, translational research, API, SaaS, drug development, data harmonization, life sciences, Andreessen Horowitz, QuartzBio, clinical sample management, genomic reference data, data analytics platform